GGrantIndex
Sort

46,585 grants matching heart failure

A Protein Replacement Drug for Friedreichs Ataxia

$1,417,065
Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR

Collaborative Pediatric Critical Care Research Network - Data Coordinating Center

$1,416,959
Jonathan Michael Dean · University Of Utah · PL1 · FY2022 · HD

Collaborative Pediatric Critical Care Research Network - Data Coordinating Center

$1,416,923
Jonathan Michael Dean · University Of Utah · PL1 · FY2023 · HD

Long Term Follow up of the Lung Transplant Outcomes Group Cohort

$1,416,878
Jason D Christie · University Of Pennsylvania · U01 · FY2024 · HL

Action for Health in Diabetes (Look AHEAD)

$1,416,848
David M Nathan · Massachusetts General Hospital · U01 · FY2008 · DK

Proteomic Profiling of Precise Exercise Pathophenotypes Across the HFpEF Spectrum

$1,416,634
Matthew G. Nayor · Boston University Medical Campus · R01 · FY2025 · HL

Local Signals and Macromolecular Architecture in Heart

$1,416,363
University Of Maryland Baltimore · P01 · FY2004 · HL

Rare variants and NHLBI traits in deeply phenotyped cohorts

$1,416,026
Bruce M Psaty · University Of Washington · R01 · FY2014 · HL

Autonomic and Imaging Biomarkers of SUDEP

$1,415,543
Samden Lhatoo · Case Western Reserve University · U01 · FY2016 · NS

Autonomic and Imaging Biomarkers of SUDEP

$1,415,543
Samden Lhatoo · Case Western Reserve University · U01 · FY2015 · NS

Autonomic and Imaging Biomarkers of SUDEP

$1,415,543
Samden Lhatoo · Case Western Reserve University · U01 · FY2017 · NS

Blood Pressure and ADRD in African Americans: the Jackson Heart Study

$1,414,700
Priya Palta · Columbia University Health Sciences · R01 · FY2020 · AG

Optimizing Cardiovascular Device Thromboresistance for Eliminating Anticoagulants

$1,414,610
Danny Bluestein · State University New York Stony Brook · U01 · FY2011 · EB

Look AHEAD: Action for Health in Diabetes

$1,414,022
Mark Andrew Espeland · Wake Forest University Health Sciences · U01 · FY2007 · DK

Vascular remodeling in patients with rare genetic disorders

$1,413,751
Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL

Improving Mitral Compensation In Ischemic Regurgitation

$1,413,244
Robert A Levine · Massachusetts General Hospital · R01 · FY2018 · HL

Automation and validation of human on a chip systems for drug discovery

$1,412,888
Michael L Shuler · Hesperos, Llc · R44 · FY2019 · TR

Digitalis-Induced Signaling by Cardiac Na+/K+-ATPase

$1,411,019
Amir Askari · University Of Toledo Health Sci Campus · P01 · FY2010 · HL

Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial

$1,408,991
Sun Yong Jeong · Translational Sciences, Inc. · R44 · FY2021 · HL

Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial

$1,408,690
Sun Yong Jeong · Translational Sciences, Inc. · R44 · FY2022 · HL

PREcision Care In Cardiac ArrEst - ICECAP (PRECICECAP)

$1,405,393
Karen G Hirsch · Stanford University · R01 · FY2022 · NS

Self Regulating Continuous Flow Total Artificial Heart

$1,404,815
Leonard Albert Richard Golding · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · HL

Cardiovascular Toxicity of Environmental Aldehydes

$1,404,693
University Of Louisville · P01 · FY2005 · ES

Long Term Follow up of the Lung Transplant Outcomes Group Cohort

$1,404,544
Jason D Christie · University Of Pennsylvania · U01 · FY2022 · HL

Automation and validation of human on a chip systems for drug discovery

$1,404,459
Michael L Shuler · Hesperos, Llc · R44 · FY2020 · TR